November 1: Use of Propensity Scores in Observational Studies of Treatment Effects-Virtual
November 1, 2023
Back to all short courses
Use of Propensity Scores in Observational Studies of Treatment Effects-Virtual
LEVEL: Intermediate
TRACK: Study Approaches
LENGTH: 4 Hours | Course runs 1 day
Wednesday, 1 November 2023 | Course runs 1 day
10:00AM – 14:00PM Eastern Daylight Time (EDT)
14:00PM – 18:00PM Coordinated Universal Time (UTC)
10:00AM – 14:00PM Eastern Daylight Time (EDT)
14:00PM – 18:00PM Coordinated Universal Time (UTC)
Click for time zone conversion
DESCRIPTION
In observational research, issues of bias and confounding relate to study design and analysis in the setting of non-random treatment assignment where compared subjects might differ substantially with respect to comorbidities. No control over the treatment
assignment and the lack of balance in the covariates between the treatment and control groups can produce confounded estimates of treatment effect. Faculty will explain how propensity scores can be used to mitigate confounding through standard
observational approaches (restriction, stratification, matching, regression, or weighting). The advantages and disadvantages of standard adjustment relative to propensity score-based methods will be discussed. Details of propensity score methodology
(variable selection, use, and diagnostics) will also be discussed. The course will also elaborate briefly on risk adjustment models that collapse predictors of outcomes and their use relative to propensity scores. This course is designed for those
having little experience with this methodology, but some knowledge of observational databases.
PREREQUISITE: Previous attendance at the short course “Introduction to the Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources,” or equivalent knowledge, is recommended.
PREREQUISITE: Previous attendance at the short course “Introduction to the Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources,” or equivalent knowledge, is recommended.
Faculty
John Seeger, PharmD, DrPH
Chief Science Officer, Epidemiology
Optum
Boston, MA, USA
Jeremy Rassen, ScD
Co-Founder, President & Chief Science Officer
Aetion, Inc.
New York, NY, USA
Basic Schedule:
Class Time: 2 hours of content | 20- to 30-minute break | 2 hours of content
Class Time: 2 hours of content | 20- to 30-minute break | 2 hours of content